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Kidney transplant biopsies in the diagnosis and management of
acute rejection reactions. In 68 consecutive renal transplant
biopsies, histopathologic changes and clinical status of the graft
recipient, both at the time of biopsy as well as one month later,
were evaluated by independent observers. Nine histologic features
were graded semiquantitatively (scale, 0 to 4): glomerular endothe-
hal swelling, proliferation, exudation and necrosis; interstitial
edema and infiltrate; vascular endothehial edema, infiltration and
necrosis. The total score for each biopsy was termed the acute
rejection index (ARI). The validity of the ARI as a means of
evaluating rejection reactions was established by correlating the
ARI with a second, overall histopathologic categorization. Clinical
status at the time of biopsy was classified by retrospective analysis
of all clinical data except the biopsy. The mean ARI of patients
with an acute clinical rejection was significantly higher than those
of patients with just a chronic clinical rejection or no clinical
rejection. The utility of the biopsy in predicting the response of the
graft recipient to therapy was evaluated in those 46 patients in
whom an acute rejection was diagnosed clinically and in whom a
full and complete course of therapy for the acute clinical rejection
was given. Of the 28 patients whom the pathologist predicted
would respond to therapy, 27 did show substantial improvement of
their renal function up to one month following institution of
treatment. Of the IS patients whom the pathologist predicted
would not respond to therapy, 15 had no clinical response. The
data suggest that the transplant biopsy is helpful in 1) establishing
the diagnosis of an acute rejection and 2) indicating whether or not
the graft recipient will respond to standard immunosuppressive
treatment for an acute rejection.
Biopsies de reins transplantés dans le diagnostic et le traitement de
reactions de rejet aigu. Dans 68 transplantations rénales con-
sCcutives les modifications histologiques du transplant et l'état
clinique du receveur ont été évalués par des observateurs in-
dépendants a Ia fois au moment de Ia biopsie puis un mois plus
tard. Neuf aspects histologiques ont été appréciés de manière semi-
quantitative (óchelle de 0 a 4): he gonfiement de l'endothélium
glomCrulaire, Ia proliferation, l'exsudation et Ia nécrose; l'oedCme
interstitiel et I'infiltration; l'oedCme endothélial, l'infiltration et ha
necrose des vaisseaux. Le total dans chaque biopsie a etC appelC
index de rejet aigu (ARI). La vahiditC de ARI dans l'Cvaluation des
reactions de rejet a etC établie en corrélant ARI avec une deuxiCme
classification histotogique globale. L'état clinique au moment de Ia
biopsie a Cté classé par l'analyse retrospective de touS les docu-
ments cliniques a l'exception de Ia biopsie. Le AR! moyen des
malades atteints de rejet aigu est significativement supCrieur a celui
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des malades atteints seulement de rejet clinique chronique ou in.
demnes de rejet clinique. L'utihité de Ia biopsie dans Ic pronostic de
Ia rCponse du receveur au traitement a été évaluCe pour les 46
malades chez lesquels un traitement de rejet aigu a etC pleinement
réalisé en doses et en durCe. Parmi les 28 malades pour lesquels
l'anatomo-pathologiste avait prCvu qu'ils rCpondraient au traite-
ment 27 ont eu une amelioration substantielle de Ia fonction rCnale
dans Ic mois qui a suivi l'institution du traitement. Parmi les 18
malades pour lesquels l'anatomo-pathologiste avait prévu qu'ils ne
répondraient pas au traitement IS n'ont eu aucun effet clinique.
Les observations suggèrent que Ia biopsie du transplant est utile
pour 1) Ctablir le diagnostic de rejet aigu et 2) indiquer si Ic
receveur rCpondra au traitement immunosuppresseur habituel du
rejet aigu.
Although the histopathologic changes associated
with acute and chronic renal allograft rejections have
been well described [1—4], the contribution of trans-
plant biopsies to the clinical management of the graft
recipient has not been well documented. Recently, it
has been suggested that a kidney biopsy, especially in
the period immediately following transplantation, is
of little clinical value [5].
Consequently, 95 renal transplant biopsies which
had been performed at Yale-New Haven Hospital
from 1968 to 1974 were evaluated; the histopatho-
logic changes were correlated with the clinical status
of the graft recipient both at the time of the biopsy as
well as one month later. The data suggest that the
transplant biopsy is helpful in 1) establishing the
diagnosis of an acute rejection episode and 2) in-
dicating whether or not the graft recipient will re-
spond to standard immunosuppressive treatment for
an acute rejection.
Methods
One hundred twenty kidney transplants have been
performed at the Yale-New Haven Hospital over the
past six years. The protocol for the management of
the graft recipient and our overall results have been
previously described [6, 7]. Ninety-five biopsies of
transplanted kidneys were performed in 75 of these
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graft recipients. Fifty-nine grafts were from cadaveric
donors and 16 were from living related donors. Clini-
cal indications for a transplant biopsy included a) an
abrupt decrease in renal function, often associated
with signs and symptoms of an acute rejection (68
biopsies); b) persistent oligo-anuria in the immediate
posttransplant period (12 biopsies); c) agradualdete-
rioration in renal function in a previously stable re-
cipient (11 biopsies); d) surgical exploration for an
unrelated problem (2 biopsies); and e) development
of heavy proteinuria (2 biopsies). Twenty-seven spec-
imens were excluded from the present analysis: 3
specimens confirmed the diagnosis of a hyperacute
rejection (widespread intravascular thrombosis with-
out interstitial infiltrate); 16 were insufficient for de-
tailed pathologic evaluation; and in 8 instances the
clinical data were insufficient for adequate classifica-
tion.
Pathologic evaluation. The remaining 68 biopsy
specimens were evaluated on each of two separate
occasions without any knowledge of the recipient's
clinical condition or subsequent course. Conven-
tional histologic sections, 2 to 4t in thickness, were
stained with hematoxylin-eosin, Masson trichrome
and Jones-Silver methanamine techniques and were
examined by light microscopy. Each biopsy specimen
was assessed for the presence of a rejection reaction,
and acute rejection was distinguished from other en-
tities such as chronic rejection without evidence of
acute rejection, tubular necrosis and recurrent dis-
ease.
The histopathologic criteria for an acute rejection
included the presence of a tubulo-interstitial nephritis
in which there was widespread interstitial edema and
focal infiltration of the cortex by lymphocytes, lym-
phoblasts, plasma cells and occasional eosinophils
(Figs. 1 and 2). In addition, swelling of the endothe-
hum of the peritubular capillaries, glomeruli and ar-
terioles was usually present. Occasionally, foci of
fibrinoid necrosis were present in the walls of small
arteries and arterioles, and fibrin thrombi with plate-
let aggregates were seen in small venules, glomerular
and peritubular capillaries and, infrequently, in arte-
rioles and larger arteriolar vessels. Foci of tubular
Fig. 1. Photomicrograph from a transplant kidney which demonstrates changes of a mild acute rejection. There is some glomerular swelling with
mild proliferation but no necrosis. Mild interstitial edema and infiltrate are present and the vessels do not show significant changes. The AR!
was 13 with a pathologic diagnosis of mild acute rejection, no evidence of chronic rejection and good likelihood of response to treatment.
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Fig. 2. Photomicrograph of a homograft biopsy specimen from a patient with a clinical diagnosis of acute rejection. There is marked interstitial
swelling and infiltrate with swelling of the endothelium of the peritubular capillaries and arterioles. The glomeruli (not shown) demonstrate
marked endothelial cell swelling and proliferation with focal areas of necrosis. The acute histologic rejection is superimposed on a chronic
histologic rejection as demonstrated by the marked myointimal proliferation of the arteries, thickening of the arteriolar wall and interstitial
fibrosis with tubular atrophy. The ARI was 25 and the pathologic diagnosis was severe acute rejection with severe chronic changes. The
likelihood of response to treatment was considered small because of the combination of severe acute and chronic histologic rejection.
necrosis and infiltration of the tubular wall with the
mixed cellular infiltrate were also sometimes present.
Chronic histologic rejection was characterized by
thickening of arterial and arteriolar walls by pro-
liferation of the myointimal cells with marked nar-
rowing of the lumen and evidence of ischemic dam-
age with glomerular hyalinization, focal interstitial
scarring and tubular atrophy.
These findings of acute allograft rejection con-
trasted with the histologic changes associated with
acute renal failure (Fig. 3). In acute renal failure,
there was usually generalized interstitial edema with
marked separation of the tubules. The tubules them-
selves appeared dilated, lined by low, slightly baso-
philic epithelium. Occasionally, foci of actual necro-
sis of the tubular epithelium with rupture of the
basement membrane could be seen. In addition, there
was generally a paucity of interstitial cellular infil-
trate in specimens with tubular necrosis, particularly
when compared with the interstitial reaction asso-
ciated with rejection. The glomeruli and vessels
showed little or no change.
Recurrence of glomerulonephritis in the allograft is
associated with demonstration of the specific gb-
merular histopathology of the original disease. Al-
though the process of albograft rejection can some-
times simulate the light microscopic changes of some
forms of primary glomerulonephritis, ultrastructural
and immunofluorescent studies helped distinguish
primary glomerular disease from the changes of an
acute rejection reaction. These studies were assessed
in those transplant biopsy specimens in which a re-
currence of primary gbomerubonephritis was sus-
pected based on the light microscopic findings. As
these additional studies were only used to distinguish
recurrent disease from a rejection episode, a detailed
analysis of immunofluorescent and electron micro-
scopic findings are not considered in the present re-
port.
The histopathologic findings by light microscopy
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Fig. 3. Photomicrograph of a biopsy specimen from a homograft recipient with a clinical diagnosis of acute renal failure. There is dilatation of
the tubules and thinning of the endothelial cells without significant changes of an acute histologic rejection. The ARt was 5 and the
pathologic diagnosis was no rejection.
were assessed on two separate occasions several
weeks apart. On the first occasion, an attempt was
made to roughly quantitate the severity of the histo-
pathologic changes. Nine features were evaluated by
scoring each feature 0 to 4 in each biopsy specimen.
The glomeruli were examined for endothelial swell-
ing, endothelial and mesangial proliferation, infil-
tration with leukocytes and necrosis. The degree of
interstitial edema and infiltrate was assessed and the
severity of the changes in the vessels, including endo-
thelial edema, mural infiltration and necrosis, were
rated. A total score for each biopsy specimen was
termed an acute rejection index (AR!) (Figs. 1—3).
On the second occasion, several weeks later, each
specimen was reevaluated without using this semi-
quantitative assessment. Each biopsy was placed in
one of five histopathologic categories on the basis of
the pathologist's overall impression of the biopsy
specimen using the criteria outlined. These categories
were as follows: no histologic rejection; chronic histo-
logic rejection without evidence of acute histologic
rejection; and mild, moderate or severe acute histo-
logic rejection. The extent of the acute histologic
rejection was termed a) mild (Fig. I), when the
changes were predominantly those of interstitial
edema with a minimal infiltrate and with little or no
vascular and glomerular involvement; b) moderate,
when the changes were more extensive and included
more extensive infiltrate and evidence of glomerular
and vascular changes; or c) severe, when in addition
there were areas of parenchymal necrosis or in-
farction. Biopsy specimens classified as no rejection
lacked the histopathologic features of either acute or
chronic rejection but had evidence of acute tubular
necrosis, obstruction or recurrence of primary dis-
ease. Specimens which had evidence of an acute his-
tologic rejection superimposed on chronic histologic
rejection were categorized only by the degree of acute
rejection in the comparison to the AR!,
During this second evaluation, an attempt was
made, based on the histopathologic changes alone, to
predict if the recipient would respond to conventional
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immunosuppressive treatment. This determination
was based both on the severity of the histopathologic
changes of acute rejection as well as the extent and
nature of chronic and irreversible changes such as
glomerular sclerosis and hyalinization, interstitial
scarring and tubular atrophy and vascular damage
and occlusion, which were present in the kidney spec-
imen. The degree of chronic histologic rejection was
classified as a) mild, when there were focal areas of
interstitial fibrosis and renal tubular atrophy without
significant glomerular or vascular changes; b) moder-
ate, when the focal interstitial scarring was accom-
panied by focal sclerosis and hyalinization of < 25%
of glomeruli and focal vascular thickening; c) severe,
when there was diffuse interstitial scarring and renal
tubular atrophy, sclerosis and hyalinization of> 50%
of glomeruli, and extensive vascular changes with
thickening of the intima and media and significant
narrowing of the lumen (Fig. 2).
Clinical evaluation. A retrospective analysis of the
graft recipient's clinical status at the time of biopsy
was made utilizing all available pre- and postbiopsy
data. Only the biopsy report itself was not reviewed
in classifying the patient's status into one of five
categories: 1) Clinical acute rejection. These patients
experienced a sudden decrease in renal function, of-
ten associated with fever, graft tenderness, abnormal
renal scan and/or other clinical features commonly
associated with an acute rejection reaction [6, 7].
Only those instances in which no other causes could
be found to explain the abnormalities were consid-
ered to be a clinical acute rejection. 2) Modified
clinical acute rejection. This category involved a clini-
cal acute rejection episode in which high dose pred-
nisone therapy had been started one to two days prior
to the time the biopsy specimen was obtained. 3)
Clinical chronic rejection. These patients had a
slowly progressive decrease in renal function, which
was unassociated with signs of an acute rejection and
which failed to respond to high dose prednisone ther-
apy. In rio instance could the decrease in renal func-
tion be related to associated problems (e.g., obstruc-
tion, hypertension or vascular stenosis). 4) Clinical
acute rejection superimposed on clinical chronic re-
jection. This category was characterized by the devel-
opment of the signs of an acute rejection episode in a
patient who had a previously stable, chronic rejec-
tion. 5) No evidence of clinical acute or clinical
chronic rejection. This category includes six patients
with acute tubular necrosis, one patient with recur-
rence of focal and segmental glomerular sclerosis,
and two patients with normal renal function who
were biopsied coincident with surgery for an unre-
lated problem.
Response to therapy. At the time of kidney biopsy,
46 patients had been diagnosed clinically to have had
an acute rejection episode and had received a full and
complete course of therapy consisting of high dose
prednisone for at least three days, and, in some cases,
radiation therapy (300 rads) and actinomycin D ad-
ministered i.v., as previously described [6]. In ad-
dition, all of these patients were classified on our
retrospective analysis to have had a clinical acute
rejection. The clinical responses to therapy were cate-
gorized as a) complete response—if the serum creati-
nine returned to less than 2 mg/tOO ml and remained
less than 2 mg/l00 ml for one month following insti-
tution of the rejection therapy; b) partial response—
if the serum creatinine concentration remained
greater than 2 mg/lOO ml during the one month
following therapy but was less than the pretreatment
serum creatinine level; and c) no response—if the
serum creatinine concentration did not remain below
the pretreatment value during the one month follow-
ing therapy. This analysis was only carried out in
those patients who received full and complete treat-
ment for the rejection episode.
Results
A cute rejection index and histopaihologic category.
The validity of the AR! as a means of identifying
acute rejection was evaluated by correlating the index
with the five histopathologic categories (Fig. 4). The
30
25>(
200
15
a)
10
5
Pathologic diagnosis
Fig. 4. Correlation of the acute rejection index with the pathologic
diagnosis. Bars indicate mean + SCM.
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scores (mean SEM) for the mild (11.9 0.6), mod-
erate (16.6 + 0.9) and severe (26.4 2.1) acute
histologic rejection categories were significantly
higher than those for the specimens with no histo-
logic evidence of rejection (4.7 0.7) or only chronic
histologic rejection (7.1 1.1). Moreover, all 16
biopsies with scores less than 10 fell into either the no
histologic rejection or only chronic histologic rejec-
tion categories, while 47 of the 48 biopsies with scores
more than 10 were in one of the acute histologic
rejection categories. The AR! could also be used as a
relative index of the severity of the rejection since the
mean score for the mild histologic rejection was sig-
nificantly lower than those of the moderate (P <
0.001) and severe histologic rejections (P < 0.001).
Since the AR! and histopathologic categorization
were done on separate occasions, these data indicate
a good correlation between the two methods and
suggest that the results are consistent with one an-
other. These findings also suggest that, while useful as
an objective criterion in this study, the AR! is no
better than the pathologist's overall impression.
In only one instance was there evidence of recur-
rent disease. In this case the recurrent disease was
focal glomerulosclerosis, there was no evidence of a
rejection reaction on biopsy and the AR! was 6.
Histopathologic score and clinical diagnosis. The
relationship of the ARI to the five clinical categories
is shown in Fig. 5. The means ARIs of patients with
the retrospective clinical diagnosis of either no evi-
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dence of clinical acute rejection (4.7 0.7) or clinical
chronic rejection (7.! + 1 .1) were significantly lower
than the scores in the three groups of patients felt to
have a clinical acute rejection. No patient with an
AR! < 10 was classified as having a clinical acute
rejection. All patients with ARIs > 12 were cate-
gorized as clinical acute rejection. The mean score of
patients classified as having a clinical acute rejection
(24.2 1.9) was also significantly higher than the
scores for patients classified as modified clinical rejec-
tion (13.7 + 1.0) or clinical acute rejection super-
imposed on chronic rejection (16.8 1.5).
Actual and predicted response to therapy (Tables 1
and 2), The utility of the biopsy in predicting the
response of the graft recipient to therapy was eval-
uated in those 46 patients who had received full and
complete treatment for a clinical acute rejection.
Table I shows a detailed analysis of the extent of both
acute and chronic histopathologic changes and the
response to therapy as predicted by the pathologist
and as actually clinically observed. Inspection of this
table indicates that the pathologist's prediction was
based on the evaluation of both the acute and chronic
histopathologic changes. The pathologist's prediction
was a) none, when, in most instances, there was mod-
erate to severe acute histologic rejection and severe
chronic histologic rejection; b) partial, when there
was moderate to severe acute histologic rejection with
only mild to moderate chronic histologic rejection;
and c) complete, when there was mild to moderate
acute histologic rejection associated with only mild or
no chronic histologic rejection.
The relationship between the predicted response to
therapy and the response actually clinically observed
is summarized in Table 2. Of the 18 patients whom
the pathologist predicted would not respond to ther-
apy, 15 had no clinical response. The remaining three
patients, who did have a partial clinical response, all
had infarcts on renal biopsy, and two of these three
lost their grafts within two months after the biopsy.
Of the 28 patients whom the pathologist predicted
would respond to therapy, 27 did show substantial
improvement of their renal function up to one month
following institution of treatment for an acute rejec-
tion. All eight patients whom the pathologist felt
would have a complete response did maintain their
serum creatinine concentration < 2 mg/lOO ml for at
least one month after treatment.
Discussion
Establishing the diagnosis of an acute rejection
episode is often difficult for the physician caring for
the renal transplant recipient. He must rely on the
development of a certain constellation of clinical and
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Acute
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Mild
Moderate
Moderate
Moderate
Moderate
Severe
Severe
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Severe
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Severe
Severe
Severe
Severe
Severe
Severe
Severe
Moderate
Moderate
Moderate
Moderate
Moderate
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Moderate
Moderate
Moderate
Moderate
Moderate
Moderate
Moderate
Moderate
Severe
Severe
Moderate
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Mild
Mild
Mild
Mild
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Moderate
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rejection
changes
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Moderate
Severe
Moderate
Severe
Severe
Severe
Severe
Severe
Severe
Mild
Mild
Mild
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Moderate
Mild
Mild
Moderate
Moderate
Mild
Moderate
Moderate
Mild
Moderate
Moderate
Moderate
Moderate
Mild
Mild
Moderate
N one
N one
Mild
None
N one
N one
None
Mild
Table 2. Correlation of actual clinical response to therapy and
response predicted from histologic exam inationa
laboratory findings to support the diagnosis. No lab-
oratory test or clinical finding alone can definitely
confirm the diagnosis of a graft rejection [8, 9]. Un-
fortunately, at the time the graft recipient develops an
abrupt deterioration of renal function, the etiology of
the changes in renal status may not be readily appar-
ent and may become obvious only as the patient's
course is carefully monitored over the next several
days or weeks. The importance of making an early
and accurate diagnosis of an acute rejection episode
is often critical for the survival of both the patient
Table 1. Pathologist's prediction and actual clinical response to
therapy for acute rejection
Actual Pathologist prediction
clinical
response None Partial Complete
None 15 I 0
Partial 3 12 0
Complete 0 7 8
Response to therapy Histopathologic evaluation
Biopsy
No.
Pathologist
prediction
None
2 None
3 None
4 None
5 None
6 None
7 None
8 None
9 None
10 None
II None
12 None
13 None
14 None
15 None
16 None
17 None
18 None
19 Partial
20 Partial
21 Partial
22 Partial
23 Partial
24 Partial
25 Partial
26 Partial
27 Partial
28 Partial
29 Partial
30 Partial
31 Partial
32 Partial
33 Partial
34 Partial
35 Partial
36 Partial
37 Partial
38 Partial
39 Complete
40 Complete
41 Complete
42 Complete
43 Complete
44 Complete
45 Complete
46 Complete
Numbers refer to number of biopsies in each category.
and his graft. Excessive use of high dose prednisone
to treat rejection significantly increases the patient's
risk of dying [6], and delayed use of steroids to treat
the rejection episode significantly lessens the change
of the graft remaining functional. Moreover, the
frequency of rejection episodes following trans-
plantation correlates well with one-year patient and
graft survival rates [7]. Thus, the accurate and certain
diagnosis of an acute rejection episode may be essen-
tial not only in the management of a graft recipient
but also in regard to treatment and long-term prog-
nosis.
The data from the present study suggest that a
transplant biopsy can help in establishing a diagnosis
of an acute rejection episode. The histologic changes
associated with acute rejections have recently been
reviewed by Corson [3]. The AR! used in the present
study was based on the characteristic histologic find-
ings of an acute rejection reaction [3]: interstitial
nephritis, glomerulitis and arteritis. The severe forms
of acute rejections, manifested histologically by a
pan nephritis [3], would be expected to have the high-
est AR!. The milder histologic reactions should have
a lower score. In the present study, the excellent
correspondence between the ARI and histopatho-
logic categorization indicates that these commonly
employed histologic criteria for determining an acute
rejection reaction are reasonably consistent and vali-
dates the AR! as a means of assessing the degree of
histologic changes present.
The type of histopathologic changes present and
the relatively low AR! (< 10) in patients thought to
have no clinical rejection or only chronic clinical
rejection suggest that a biopsy of a transplanted kid-
ney can distinguish an acute clinical rejection from
other commonly associated problems. This sub-
stantiation of the clinical diagnosis is particularly
important in those situations in which the clinical
diagnosis of an acute rejection is unclear, as often
occurs in the period immediately following trans-
plantation. In addition, the biopsy may be important
in differentiating patients who have an acute clinical
rejection superimposed on stable chronic rejection
from those with only chronic clinical rejection and
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slowly deteriorating renal function. Nevertheless, his-
topathologic changes and the ARI alone could not
distinguish other less commonly encountered prob-
lems such as an acquired acute glomerulonephritis or
acute interstitial nephritis. However, in such in-
stances, one would anticipate additional clinical,
laboratory and histopathologic findings (electron
microscopic and immunofluorescent) suggestive of a
diagnosis other than an acute rejection.
Moreover, data from the present analysis indicate
that a homograft biopsy may be beneficial in deter-
mining the likelihood of a response to therapy. In 18
patients the histopathologic changes were predictive
of no response to therapy and only three of these
patients (17%) had a clinical response. In each of
these three cases an infarcted area of the graft had
been biopsied and two of these patients lost their
allograft within two months after biopsy. Thus, while
in some cases severe histopathologic changes on
biopsy may represent a sampling error and, con-
sequently, the recipient may respond to therapy, the
long-term implications of changes such as infarction
are ominous, Conversely, of 28 patients who were
predicted to respond to therapy by histologic eva!-
uation, only one failed to have a clinical response.
A technical consideration of importance is that if
the biopsy is to be clinically helpful, it must be avail-
able promptly. The routine practice in our laboratory
allows light, electron and immunofluorescent micro-
scopy to be available as early as 6 hr and no later than
24 hr after the biopsy. Simple and generally utilized
techniques, therefore, allow histologic examination
to be a clinically useful tool.
In summary, the renal transplant biopsy can be
helpful in establishing the diagnosis of an acute clini-
cal rejection and in predicting the response of an
acute rejection to therapy. Clearly, a biopsy is not
always needed to clarify the diagnosis of an acute
rejection; the clinical situation often provides suf-
ficient diagnostic clues. But, in those instances in
which the diagnosis is not readily apparent at the
time of deteriorating renal function, the transplant
biopsy can provide useful information for the physi-
cian caring for the graft recipient.
Reprint requests to Dr. Fredric 0. Finkelstein, Department of
Internal Medicine, Yale University School of Medicine, 333 Cedar
Street, New Haven, Connecticut 06510, U.S.A.
References
I. HULME B, ANDRES GA, PORTER KA, OGDEN DA: Human renal
transplants: IV. Glomerular ultrastructure, macromolecular
permeability and hemodynamics. Lab Invest 26:2—10, 1972
2. PORTER KA, ANDRES GA, COLDER MW, DOSSITOR JB, Hsu
KC, RANDALL JM, SEEGAL BC, STARZL TE: Human renal
transplants: II. Immunofluorescent and immunoferritin studies.
Lab Invest 18:159—171, 1968
3. CORSON JM: The pathologist and the kidney transplant. Patho!
Annu 7:251—292, 1972
4. LINDQUIST RR, GUTMANN RD, MERRILL JP, DAMMIN GJ: Hu-
man renal allografts: Interpretation of morphologic and im-
munohistochemical observations. Am J Pathol 53:851—88!,
1968
5. MERRILL JP: Present studies of kidney transplantation. Disease-
a-month, November, 1972
6. FINKELSTEIN FO, BLACK HR: Risk factor analysis in renal
transplantation. Am J Med Sci 267:159—169, 1974
7. FINKELSTEIN FO, LYTTON B, SCHIFF M, BLACK HR: Rejection
episodes and patient and graft survival after renal trans-
plantation. Clin Nephrol 3:217—221, 1975
8. MERRILL JP: Diagnosis and management of rejection in allo-
grafted kidneys. Transplant Proc 3:287—292, 1971
9. MAHER JF: A logical approach to the diagnosis of renal trans-
plant rejection: Immunologic, ischemic and inflammatory im-
pairment of renal function. Am J Med 56:275—279, 1974
